Suspended

International GNE Myopathy Patient Registry (GNE001)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Muscular Diseases+6

+ Muscular Dystrophies

+ Musculoskeletal Diseases

Over 18 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: March 2014
See protocol details

Summary

Principal SponsorNewcastle University
Study ContactRegistry Curator
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2014

Actual date on which the first participant was enrolled.

GNE myopathy is an ultra- rare condition. Most of the knowledge is coming from case reports or small cohort observations. There is a need to more precisely understand the long-term disease course and the progression of disease-specific features of GNE myopathy, and in turn characterise the overall burden of this illness. Also, to better understand the disease, describe it variability, genotype-phenotype correlation, quality of life, epidemiology, health-economics aspects and need for assistive walking devices. Collected data needs to be harmonised to be compatible collaborative work with Remudy (Japanese patient registry). This collaborative effort will enable the analysis of the largest GNE myopathy data set in the world. To this end, this study will collect patient information longitudinally. Upon patient's agreement, the registry curator can contact nominated clinicians to request additional data or data validation. Study Objectives The objectives of the study are to: * Longitudinally characterize disease-specific features of GNE myopathy * Characterize the burden of illness and quality of life in patients with GNE myopathy * Support recruitment in research activities * Inform registry participants via newsletters about scientific developments in the GNE myopathy field

Official TitleInternational GNE Myopathy Patient Registry (GNE001)
NCT04009226
Principal SponsorNewcastle University
Study ContactRegistry Curator
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

430 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Muscular DiseasesMuscular DystrophiesMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System DiseasesNeuromuscular DiseasesMuscular Disorders, AtrophicGenetic Diseases, InbornDistal Myopathies

Criteria

3 inclusion criteria required to participate
Aged 18 years or older at the time of informed consent

Clinical and/or genetic diagnosis of GNE myopathy (also known as HIBM, QSM, Inclusion Body Myopathy Type 2, DMRV, or Nonaka disease)

Willing and able to provided electronic (or written) consent and comply with all study requirements.

1 exclusion criteria prevent from participating
Under 18 years of age

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

John Walton Muscular Dystrophy Research Centre

Newcastle upon Tyne, United KingdomOpen John Walton Muscular Dystrophy Research Centre in Google Maps
SuspendedOne Study Center
International GNE Myopathy Patient Registry (GNE001) | PatLynk